Jack Glenn

Chief Financial Officer

Mr. Glenn joined Ekso Bionics as its Chief Financial Officer in August 2018. He brings more than 25 years of financial leadership experience to this role, within both public and private companies in the life science industry. Most recently, Mr. Glenn served as CFO for Sonendo, Inc., a privately-held, venture-backed company. Prior to this, his experience also includes serving as CFO at several other companies, including Armetheon Corporation, a privately-held biopharmaceutical company; Solta Medical, where he assisted in the company’s strategic acquisition by Valeant Pharmaceutical; Cholestech, which was acquired by Alere Medical; and Invivo Corporation, which was sold to Intermagnetics General Corporation. Mr. Glenn received his MBA in Finance from Santa Clara University and his B.S. in Business Administration from the University of Nevada.

View all Leaders